The LINXS mAb Final Meeting will be held as a lunch-to-lunch event at LINXS in Lund and is welcoming anyone interested in the LINXS antibody consortium’s collaborative experimental, simulation, and theoretical efforts to advance the understanding of antibodies in solution and the progress made in recent years.
The event will feature scientific presentations, insights from the pharmaceutical industry and NIST (National Institute of Standards and Technology), as well as a roundtable discussion on “lessons learned and loose ends”.